Investor Webinar


Invest with us in the Protein Revolution


Cars replaced horses, petroleum replaced whales, tractors replaced oxen, telecommunications replaced carrier pigeons, fermentation replaced cows and pigs for insulin production. And despite its many shortcomings, plastic continues to take market share from leather. Wherever we look, humans have consistently built technologies that surpass their animal predecessors. Food may be next.

All over the world, entrepreneurs are reinventing how we make products we’ve traditionally derived from animals, and startups like Beyond Meat and Impossible Foods are only the begining. Applying the latest technologies from biotech, tissue engineering, artificial intelligence, and food science, entrepreneurs are trying to create new animal-free products that are cheaper, healthier, tastier, and more sustainable. Even if they’re moderately successful, they’ll have an opportunity to capture a meaningful portion of the $2.9 trillion dollar animal products market. Opportunities don’t come much bigger than that. As venture capitalists, this is hard to ignore.

We established AgFunder's New Carnivore fund to invest in startups working to create non-animal based protein alternatives including plant-based meat alternatives, cellular agriculture, and the picks and shovels technologies required to enable this emerging industry. 

Read our investment thesis, Why technology may make animals obsolete on AgFunderNews.

Investor Presentation 


dl-pres.png

Download Whitepaper


wp_cover.png

Fund Overview


> Market Opportunity

$2.96 trillion market for animal products, with alternative protein expected to capture 5-10% by 2025.

> Investment Opportunity

Dedicated fund to invest in ~20 startups (pre-Seed to pre-IPO) globally that are pioneering the alternative protein sector.

> Structure

$20 million fund with up to 50% reserved for follow on. 10-year fund life.

> Why AgFunder

Founded in 2013 and based in Silicon Valley, AgFunder is one of the most active foodtech and agtech VCs globally. We've coinvested with Andreessen Horowitz, Data Collective, Felicis Ventures, Horizons Ventures, TPG, True Ventures, and others, and our first funds are tracking 20%+ IRR. Our investment team has deep technical capabilities including two biology PhDs from Yale and Stanford. Our media publication AgFunder News is a cornerstone of the industry with over 75k subscribers giving us a global network and visibility.

Learn More


The closing period for investors investing <$1m ended on December 15, 2019. Investors investing $1m+ have until the second close in Spring 2020. To learn more email us at funds@agfunder.com.

 



IMPORTANT NOTICES

  • AGFUNDER FUNDS ARE AVAILABLE TO ACCREDITED INVESTORS ONLY
  • PAST FUND OR PORTFOLIO PERFORMANCE IS NOT AN INDICATOR OF FUTURE RESULTS
  • THE OFFER AND SALE OF MEMBERSHIP INTERESTS IN ANY AGFUNDER FUND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR UNDER ANY APPLICABLE STATE OR FOREIGN SECURITIES LAWS (AND THE FUNDS ARE UNDER NO OBLIGATION TO REGISTER THE MEMBERSHIP INTERESTS IN THE FUTURE), NOR HAVE SUCH MEMBERSHIP INTERESTS BEEN APPROVED OR DISAPPROVED BY THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION (THE “SEC”) OR THE SECURITIES REGULATORY AUTHORITY OF ANY STATE OR FOREIGN JURISDICTION. NEITHER THE SEC NOR ANY COMMISSIONER OF ANY SUCH STATE OR NON-U.S. AUTHORITY HAS PASSED UPON THE ACCURACY OR ADEQUACY OF ANY MATERIAL RELATED TO THE FUNDS AND ANY REPRESENTATION TO THE CONTRARY IS UNLAWFUL. THIS PAGE DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF INTEREST TO PURCHASE ANY SECURITIES OR INVESTMENT ADVISORY SERVICES IN ANY STATE OR IN ANY OTHER JURISDICTION IN WHICH SUCH OFFER OR SOLICITATION IS NOT PERMITTED BY LAW.
  • PROSPECTIVE INVESTORS ARE NOT TO CONSTRUE THE CONTENTS OF THIS WEBSITE OR ANY PRIOR OR SUBSEQUENT COMMUNICATION FROM AGFUNDER OR ANY OF ITS REPRESENTATIVES OR AFFILIATES, AS LEGAL, TAX, OR INVESTMENT ADVICE. EACH INVESTOR SHOULD CONSULT WITH AND RELY ON HIS, HER OR ITS OWN PERSONAL COUNSEL, ACCOUNTANT, OR OTHER ADVISORS AS TO LEGAL, TAX, AND ECONOMIC IMPLICATIONS OF AN INVESTMENT IN ANY AGFUNDER FUND AND ITS SUITABILITY FOR SUCH INVESTOR.